1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9

Results for "1926203-09-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-122487


    Others Neurological Disease
    Troriluzole, a third-generation, tripeptide prodrug of Riluzole (HY-B0211), is an orally active glutamate modulator. Troriluzole reduces synaptic glutamate level and increases the synaptic glutamate absorption. Troriluzole has the potential for Alzheimer disease and generalized anxiety disorder (GAD).